Hanna Savolainen-Peltonen
1 clinical trials · Sponsor
◉ Watch Hanna Savolainen-Peltonen
| Record | Firm | Date |
|---|---|---|
| Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life (NCT04050592) | Hanna Savolainen-Peltonen | 2020-02-19 |
Track Hanna Savolainen-Peltonen automatically
Every clearance here is in the API, with alerts when new ones post.